Medical Costs Regarding the important economic aspects, all the highly significant studies available in the literature confirm that pneumococcal vaccinations are cost-effective in children, adults, and in elderly patients [ 91 , 92 ].
← all excerpts
Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance.
1
—
—